Approval Of Wyeth's Experimental Drug Pristiq As Depression Treatment Will Not Be Delayed By FDA, Company Officials Say

Main Category: Depression
Also Included In: Pharma Industry / Biotech Industry;  Women's Health / Gynecology
Article Date: 06 Aug 2007 - 9:00 PDT

Current ratings for:
'Approval Of Wyeth's Experimental Drug Pristiq As Depression Treatment Will Not Be Delayed By FDA, Company Officials Say'

Patient / Public:4 stars

3.67 (3 votes)

Healthcare Prof:4 and a half stars

4.5 (2 votes)


FDA's request for more data on Wyeth's experimental drug Pristiq as a nonhormonal treatment for hot flashes and other menopausal symptoms should not delay its approval as a depression treatment, company officials said Tuesday, the AP/BusinessWeek reports (Johnson, AP/BusinessWeek, 7/31).

Pristiq is a new version of Wyeth's depression treatment Effexor, which will lose patent protection in 2010. Wyeth is seeking approval from FDA to market Pristiq as a depression treatment for older women, as well as a treatment for menopausal symptoms. FDA last week issued an approvable letter for Pristiq as a menopausal-symptom treatment, which means that the agency could approve the drug but also usually means the agency needs more information before granting final approval.

According to Wyeth, FDA in its letter said that before the application could be approved, Wyeth must provide additional data on the potential for serious adverse cardiovascular and hepatic effects associated with the use of Pristiq. In addition, FDA said that Wyeth must address certain chemistry, manufacturing and control deficiencies prior to approval. FDA also made additional clinical and chemistry requests, which it said were not approvability issues (Kaiser Daily Women's Health Policy Report, 7/24).

Wyeth officials said they will work with FDA to speed the drug's approval as a nonhormonal treatment for menopausal symptoms. Greg Norden, Wyeth's CFO, said FDA officials have reassured the company that the additional safety data required for approval as a menopausal symptom treatment will not delay approval of the drug as a depression treatment. "We continue to believe [Pristiq] will receive approval in the first quarter of 2008" for depression, Norden said (AP/BusinessWeek, 7/31).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

View drug information on Effexor.


Article adapted by Medical News Today from original press release.
Visit our depression section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "Approval Of Wyeth's Experimental Drug Pristiq As Depression Treatment Will Not Be Delayed By FDA, Company Officials Say." Medical News Today. MediLexicon, Intl., 6 Aug. 2007. Web.
26 May. 2012. <http://www.medicalnewstoday.com/releases/78629.php>

APA
Kaiser. (2007, August 6). "Approval Of Wyeth's Experimental Drug Pristiq As Depression Treatment Will Not Be Delayed By FDA, Company Officials Say." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/78629.php.

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Approval Of Wyeth's Experimental Drug Pristiq As Depression Treatment Will Not Be Delayed By FDA, Company Officials Say'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Your Name:*
E-mail Address:*
Your Opinion Title:*
Opinion:*
This is to help prevent SPAM submissions. Please enter the words exactly as they appear, including capital letters and punctuation.*

* Fields marked with a * need to be filled in before you hit the submit button.

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.


Depression

What Is Depression?

Feeling sad, or what we may call "depressed", happens to all of us. The sensation usually passes after a while. However, a person with a depressive disorder - clinical depression - finds that his state interferes with his daily life. Read more...

What Are The Symptoms Of Depression?

When feelings of sadness and being unable to cope overwhelm the person, so much so that they undermine their ability to live a normal and active life, it is possible that they have depression. Read more...

Most Popular Articles



Follow Our Depression News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Depression Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »